Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases | Patent Number 08148342

US 08148342 B2
Application Number12008578
Publication NumberUS 20080287382 A1
Pendency4 years, 2 months, 24 days
Filled DateJan 11, 2008
Priority DateSep 28, 2004
Publication DateNov 20, 2008
Expiration DateSep 28, 2024
Inventor/ApplicantsShai Ehrlich
Elena Feinstein
Daniel Zurr
ExaminesVIVLEMORE, TRACY ANN
Art Unit1635
Technology Center1600
Assignments
Quark Pharmaceuticals Inc.
Current
Quark Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.